Ddx4tm1.1(cre)Dcp/Ddx4+
Rb1tm3Tyj/Rb1tm3Tyj
involves: 129S4/SvJae * C57BL/6
|
abnormal fertility/fecundity |
J:198777
|
|
abnormal spermatogenesis |
J:198777
|
|
decreased testis weight |
J:198777
|
|
male infertility |
J:198777
|
|
small testis |
J:198777
|
Rb1tm1.1Gfk/Rb1tm1.1Gfk
Tg(Tyr-cre)1Gfk/0
involves: 129T2/SvEms * C57BL/6 * SJL
|
abnormal melanocyte morphology |
J:108628
|
|
postnatal lethality, complete penetrance |
J:108628
|
Rb1tm1.1Jyjw/Rb1+
either: (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6) or (involves: 129S4/SvJae * 129S6/SvEvTac)
|
abnormal pilomotor reflex |
J:80087
|
|
decreased apoptosis |
J:80087
|
|
decreased retina apoptosis |
J:80087
|
|
decreased susceptibility to induced morbidity/mortality |
J:80087
|
|
lethargy |
J:80087
|
Rb1tm1.1Jyjw/Rb1tm1.1Jyjw
129S6.129-Trp53tm1Tyj Rb1tm1.1Jyjw
|
normal
neoplasm |
J:102483
|
Rb1tm1.1Jyjw/Rb1tm1.1Jyjw
either: (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6) or (involves: 129S4/SvJae * 129S6/SvEvTac)
|
abnormal pilomotor reflex |
J:80087
|
|
abnormal retina apoptosis |
J:80087
|
|
decreased apoptosis |
J:80087
|
|
decreased susceptibility to induced morbidity/mortality |
J:80087
|
|
increased susceptibility to induced morbidity/mortality |
J:80087
|
|
lethargy |
J:80087
|
|
prenatal lethality, incomplete penetrance |
J:80087
|
Rb1tm1.2Gfk/Rb1+
involves: 129T2/SvEms * C57BL/6 * SJL
|
decreased tumor-free survival time |
J:108628
|
|
increased tumor incidence |
J:108628
|
Rb1tm1.2Gfk/Rb1tm1.2Gfk
involves: 129T2/SvEms * C57BL/6 * SJL
|
preweaning lethality, incomplete penetrance |
J:108628
|
Rb1tm1Brd/Rb1+
involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J
|
increased pheochromocytoma incidence |
J:79016
|
|
increased pituitary adenohypophysis tumor incidence |
J:79016
|
|
increased pituitary melanotroph tumor incidence |
J:79016
|
|
increased thyroid C-cell carcinoma incidence |
J:79016
|
Rb1tm1Brd/Rb1+
involves: 129S7/SvEvBrd * C57BL/6
|
abnormal neuroendocrine gland morphology |
J:17434
|
|
cachexia |
J:17434
|
|
increased body mass index |
J:79648
|
|
increased brain tumor incidence |
J:2516
|
|
increased metastatic potential |
J:17434
|
|
increased pituitary adenoma incidence |
J:17434
|
|
normal
neoplasm |
J:2516,
J:79648
|
|
obese |
J:17434
|
Rb1tm1Brd/Rb1tm1Brd
involves: 129S7/SvEvBrd * C57BL/6
|
abnormal blood vessel morphology |
J:2516
|
|
abnormal brain morphology |
J:2516
|
|
abnormal cell proliferation |
J:2516
|
|
abnormal dorsal root ganglion morphology |
J:2516
|
|
abnormal embryo development |
J:2516
|
|
abnormal erythrocyte morphology |
J:2516
|
|
decreased brain size |
J:2516
|
|
decreased fetal size |
J:2516
|
|
decreased hepatocyte number |
J:2516
|
|
dilated liver sinusoidal space |
J:2516
|
|
edema |
J:2516
|
|
enlarged fourth ventricle |
J:2516
|
|
increased neuron apoptosis |
J:2516
|
|
increased nucleated erythrocyte cell number |
J:2516
|
|
kyphosis |
J:2516
|
|
lethality throughout fetal growth and development, complete penetrance |
J:2516
|
|
small dorsal root ganglion |
J:2516
|
|
small liver |
J:2516
|
|
normal
vision/eye phenotype |
J:2516
|
Rb1tm1Brn/Rb1+
Tg(Pomc-FLP)1aBrn/0
involves: 129P2/OlaHsd * FVB/N
|
abnormal pituitary intermediate lobe morphology |
J:48860
|
|
increased pituitary adenoma incidence |
J:48860
|
Rb1tm1Brn/Rb1+
X/Tg(Pomc-FLP)1bBrn
involves: 129P2/OlaHsd * FVB/N
|
pituitary intermediate lobe hyperplasia |
J:48860
|
Rb1tm1Brn/Rb1tm1Brn
involves: 129P2/OlaHsd * FVB/N
|
no abnormal phenotype detected |
J:48860
|
Rb1tm1Brn/Rb1tm1Brn
Tg(Pomc-FLP)1aBrn/0
involves: 129P2/OlaHsd * FVB/N
|
increased pituitary adenoma incidence |
J:48860
|
|
premature death |
J:48860
|
Rb1tm1Brn/Rb1tm1Brn
X/Tg(Pomc-FLP)1bBrn
involves: 129P2/OlaHsd * FVB/N
|
decreased tumor-free survival time |
J:48860
|
|
increased pituitary adenoma incidence |
J:48860
|
|
pituitary intermediate lobe hyperplasia |
J:48860
|
Rb1tm1Dwg/Rb1tm1Dwg
involves: 129/Sv * C57BL/6
|
abnormal cell cycle |
J:105548
|
|
abnormal cell cycle checkpoint function |
J:105548
|
|
abnormal dorsal root ganglion morphology |
J:105548
|
|
abnormal erythropoiesis |
J:105548
|
|
abnormal fourth ventricle morphology |
J:105548
|
|
abnormal lens fiber morphology |
J:105548
|
|
abnormal macrophage morphology |
J:105548
|
|
abnormal placenta labyrinth morphology |
J:105548
|
|
abnormal placental transport |
J:105548
|
|
abnormal third ventricle morphology |
J:105548
|
|
abnormal trigeminal ganglion morphology |
J:105548
|
|
decreased embryo size |
J:105548
|
|
increased fibroblast proliferation |
J:105548
|
|
increased lens fiber apoptosis |
J:105548
|
|
lethality throughout fetal growth and development, complete penetrance |
J:105548
|
|
pallor |
J:105548
|
Rb1tm1Dwg/Rb1tm1Tyj
involves: 129/Sv * 129S2/SvPas * C57BL/6
|
abnormal erythropoiesis |
J:105548
|
|
decreased embryo size |
J:105548
|
|
lethality throughout fetal growth and development, complete penetrance |
J:105548
|
|
pallor |
J:105548
|
Rb1tm1Dwg/Rb1tm2Brn
Tg(Chx10-EGFP/cre,-ALPP)2Clc/0
involves: 129/Sv * C57BL/6 * SJL
|
abnormal retina horizontal cell morphology |
J:105548
|
|
decreased retina rod cell number |
J:105548
|
Rb1tm1Fad/Rb1tm1Fad
involves: 129 * C57BL/6
|
abnormal chromosome morphology |
J:108366
|
|
abnormal milk ejection |
J:151417
|
|
abnormal mitosis |
J:108366
|
|
abnormal response/metabolism to endogenous compounds |
J:151417
|
|
aneuploidy |
J:108366
|
|
mammary gland duct hyperplasia |
J:151417
|
|
mammary gland hyperplasia |
J:151417
|
Rb1tm1Jyjw/Rb1+
either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6)
|
abnormal pilomotor reflex |
J:80087
|
|
abnormal retina apoptosis |
J:80087
|
|
decreased apoptosis |
J:80087
|
|
decreased susceptibility to induced morbidity/mortality |
J:80087
|
|
lethargy |
J:80087
|
Rb1tm1Jyjw/Rb1tm1Jyjw
either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6)
|
abnormal pilomotor reflex |
J:80087
|
|
decreased apoptosis |
J:80087
|
|
decreased retina apoptosis |
J:80087
|
|
decreased susceptibility to induced morbidity/mortality |
J:80087
|
|
increased susceptibility to induced morbidity/mortality |
J:80087
|
|
lethargy |
J:80087
|
|
prenatal lethality, incomplete penetrance |
J:80087
|
Rb1tm1Mlh/Rb1+
either: 129P2/OlaHsd-Rb1tm1Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N)
|
abnormal dorsal root ganglion morphology |
J:2498
|
|
increased pituitary melanotroph tumor incidence |
J:20542
|
|
normal
neoplasm |
J:2498,
J:20542
|
Rb1tm1Mlh/Rb1tm1Mlh
either: 129P2/OlaHsd-Rb1tm1Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N)
|
abnormal definitive hematopoiesis |
J:2498
|
|
abnormal dorsal root ganglion morphology |
J:2498
|
|
abnormal erythrocyte morphology |
J:2498
|
|
abnormal erythropoiesis |
J:2498,
J:20542
|
|
abnormal frontal lobe morphology |
J:2498
|
|
abnormal lens fiber morphology |
J:20542
|
|
abnormal myelopoiesis |
J:2498
|
|
decreased erythrocyte cell number |
J:2498
|
|
decreased hepatocyte number |
J:20542
|
|
dilated fourth ventricle |
J:2498
|
|
dilated liver sinusoidal space |
J:2498
|
|
embryonic growth retardation |
J:2498
|
|
embryonic lethality, complete penetrance |
J:2498
|
|
flat forehead |
J:2498
|
|
increased apoptosis |
J:2498
|
|
increased megakaryocyte cell number |
J:2498
|
|
neurodegeneration |
J:2498,
J:20542
|
|
pale yolk sac |
J:2498
|
|
normal
vision/eye phenotype |
J:20542
|
Rb1tm1Tyj/Rb1+
involves: 129S2/SvPas
|
increased pituitary gland tumor incidence |
J:215358
|
|
postnatal lethality, incomplete penetrance |
J:215358
|
Rb1tm1Tyj/Rb1+
involves: 129S2/SvPas * 129S6/SvEvTac * FVB/N
|
increased pituitary gland tumor incidence |
J:175625
|
|
increased thyroid tumor incidence |
J:175625
|
|
premature death |
J:175625
|
Rb1tm1Tyj/Rb1+
involves: 129S2/SvPas * C57BL/6
|
cachexia |
J:2511
|
|
increased pituitary gland tumor incidence |
J:2511,
J:81082
|
|
increased thyroid tumor incidence |
J:81082
|
|
normal
neoplasm |
J:2511
|
|
premature death |
J:81082
|
Rb1tm1Tyj/Rb1+
involves: 129S2/SvPas * C57BL/6J
|
increased lung tumor incidence |
J:133299
|
|
increased metastatic potential |
J:133299
|
|
increased pheochromocytoma incidence |
J:133299
|
|
increased pituitary adenohypophysis tumor incidence |
J:133299
|
|
increased pituitary melanotroph tumor incidence |
J:133299
|
|
increased thyroid C-cell carcinoma incidence |
J:133299
|
|
premature death |
J:133299
|
Rb1tm1Tyj/Rb1tm1Tyj
involves: 129S2/SvPas
|
abnormal cell cycle |
J:105548
|
|
abnormal cell cycle checkpoint function |
J:105548
|
|
abnormal dorsal root ganglion morphology |
J:105548
|
|
abnormal erythropoiesis |
J:105548
|
|
abnormal fourth ventricle morphology |
J:105548
|
|
abnormal lens development |
J:81643
|
|
abnormal lens fiber morphology |
J:105548
|
|
abnormal macrophage differentiation |
J:105548
|
|
abnormal neuron differentiation |
J:81643
|
|
abnormal placenta labyrinth morphology |
J:105548
|
|
abnormal placental transport |
J:105548
|
|
abnormal third ventricle morphology |
J:105548
|
|
abnormal trigeminal ganglion morphology |
J:105548
|
|
decreased embryo size |
J:105548
|
|
embryonic lethality during organogenesis, complete penetrance |
J:105548
|
|
hypoxia |
J:81643
|
|
increased fibroblast proliferation |
J:105548
|
|
increased lens fiber apoptosis |
J:105548
|
|
increased neuron apoptosis |
J:81643
|
|
increased nucleated erythrocyte cell number |
J:81643
|
|
liver hypoplasia |
J:81643
|
|
pallor |
J:105548
|
Rb1tm1Tyj/Rb1tm1Tyj
involves: 129S2/SvPas * 129S6/SvEvTac * FVB/N
|
abnormal cell differentiation |
J:175625
|
|
embryonic lethality, complete penetrance |
J:175625
|
Rb1tm1Tyj/Rb1tm1Tyj
involves: 129S2/SvPas * C57BL/6
|
abnormal cartilage morphology |
J:37145
|
|
abnormal erythrocyte morphology |
J:2511
|
|
abnormal erythropoiesis |
J:2511
|
|
abnormal liver morphology |
J:2511
|
|
anemia |
J:2511
|
|
hunched posture |
J:37145
|
|
increased apoptosis |
J:37145
|
|
increased cell proliferation |
J:81082
|
|
increased neuron apoptosis |
J:2511
|
|
lethality throughout fetal growth and development, complete penetrance |
J:2511,
J:81082
|
|
low mean erythrocyte cell number |
J:2511
|
|
normal
nervous system phenotype |
J:92520
|
|
pericardial edema |
J:2511
|
|
skin edema |
J:2511
|
|
small liver |
J:2511
|
|
normal
vision/eye phenotype |
J:2511
|
Rb1tm1Tyj/Rb1tm2Tyj
chimera involves: 129S2/SvPas * C57BL/6
|
abnormal hepatocyte morphology |
J:59268
|
|
abnormal Purkinje cell morphology |
J:59268
|
|
cachexia |
J:59268
|
|
cataract |
J:59268
|
|
ectopic Purkinje cell |
J:59268
|
|
increased pituitary adenoma incidence |
J:59268
|
|
normal
nervous system phenotype |
J:59268
|
|
preneoplasia |
J:59268
|
|
thin cerebellar granule layer |
J:59268
|
|
normal
vision/eye phenotype |
J:59268
|
Rb1tm2.1Brn/Rb1tm2.1Brn
Not Specified
|
lethality throughout fetal growth and development, complete penetrance |
J:77982
|
Rb1tm2.1Dwg/Rb1tm2.1Dwg
B6.129S4-Rb1tm2.1Dwg
|
no abnormal phenotype detected |
J:158408
|
Rb1tm2.1Fad/Rb1tm2.1Fad
involves: 129 * C57BL/6
|
normal
cellular phenotype |
J:215358
|
|
normal
digestive/alimentary phenotype |
J:215358
|
|
mammary gland duct hyperplasia |
J:215358
|
|
neonatal lethality, incomplete penetrance |
J:215358
|
|
normal
neoplasm |
J:215358
|
|
normal
nervous system phenotype |
J:215358
|
|
respiratory distress |
J:215358
|
|
skeletal muscle atrophy |
J:215358
|
Rb1tm2.1Jyjw/Rb1tm2.1Jyjw
involves: 129 * C57BL/6
|
abnormal milk ejection |
J:151417
|
|
abnormal response/metabolism to endogenous compounds |
J:151417
|
|
mammary gland duct hyperplasia |
J:151417
|
|
mammary gland hyperplasia |
J:151417
|
Rb1tm2Brn/Rb1tm2Brn
involves: 129
|
normal
neoplasm |
J:86077,
J:157319
|
|
normal
respiratory system phenotype |
J:86077
|
Rb1tm2Brn/Rb1tm2Brn
involves: 129 * BALB/c
|
abnormal white adipose tissue morphology |
J:129672
|
Rb1tm2Brn/Rb1tm2Brn
Tg(Col1a1-cre)1Bek/0
involves: 129 * CD-1
|
abnormal hearing physiology |
J:96345
|
|
abnormal organ of Corti morphology |
J:96345
|
|
abnormal organ of Corti supporting cell proliferation |
J:96345
|
|
increased cochlear hair cell number |
J:96345
|
|
increased cochlear inner hair cell number |
J:96345
|
|
increased cochlear outer hair cell number |
J:96345
|
|
increased Deiters cell number |
J:96345
|
|
increased vestibular hair cell number |
J:96345
|
|
perinatal lethality |
J:96345
|
Rb1tm2Brn/Rb1tm2Brn
Tg(Cyp1a1-cre)1Dwi/0
involves: 129 * C57BL/6 * CBA
|
abnormal enterocyte proliferation |
J:215358
|
Rb1tm2Brn/Rb1tm2Brn
Tg(En2-cre)22Alj/0
involves: 129P2/OlaHsd * CD-1
|
abnormal brain interneuron morphology |
J:83783
|
|
abnormal cerebellar cortex morphology |
J:83783
|
|
abnormal cerebellar granule cell morphology |
J:83783
|
|
abnormal cerebellar granule layer morphology |
J:83783
|
|
abnormal cerebellum external granule cell layer morphology |
J:83783
|
|
abnormal neuronal precursor proliferation |
J:83783
|
|
abnormal Purkinje cell morphology |
J:83783
|
|
astrocytosis |
J:83783
|
|
increased neuron apoptosis |
J:83783
|
|
thin external granule cell layer |
J:83783
|
Rb1tm2Brn/Rb1tm2Brn
Tg(Gfap-cre)2Brn/0
involves: 129 * FVB/N
|
increased carcinoma incidence |
J:187257
|
|
increased pituitary gland tumor incidence |
J:187257
|
|
normal
neoplasm |
J:61961
|
|
premature death |
J:187257
|
Rb1tm2Brn/Rb1tm2Brn
Tg(MMTV-cre)105Ayn/0
FVB.Cg-Rb1tm2Brn Tg(MMTV-cre)105Ayn
|
normal
neoplasm |
J:165292
|
Rb1tm2Brn/Rb1tm2Brn
Tg(Myh6-cre)2182Mds/Tg(Myh6-cre)2182Mds
involves: 129 * FVB
|
no abnormal phenotype detected |
J:97589
|
Rb1tm2Brn/Rb1tm2Brn
Tg(Pcp2-cre)756Mro/0
involves: 129P2/OlaHsd * FVB
|
abnormal cerebellum vermis morphology |
J:83783
|
Rb1tm2Brn/Rb1tm2Brn
Tg(Pou4f3-cre)1Devet/0
involves: 129 * 129S/SvEv
|
abnormal cochlear hair cell morphology |
J:109453
|
|
abnormal cochlear outer hair cell morphology |
J:109453
|
|
abnormal organ of Corti morphology |
J:109453
|
|
abnormal organ of Corti supporting cell proliferation |
J:109453
|
|
abnormal vestibular hair cell morphology |
J:109453
|
|
abnormal vestibular system physiology |
J:109453
|
|
circling |
J:109453
|
|
cochlear hair cell degeneration |
J:109453
|
|
cochlear outer hair cell degeneration |
J:109453
|
|
deafness |
J:109453
|
|
impaired swimming |
J:109453
|
|
increased cochlear inner hair cell number |
J:109453
|
|
increased cochlear outer hair cell number |
J:109453
|
|
vestibular hair cell degeneration |
J:109453
|
Rb1tm2Brn/Rb1tm2Brn
Tg(Rbp3-cre)1Brn/0
involves: 129 * FVB/N
|
increased pituitary adenohypophysis tumor incidence |
J:77982
|
|
increased pituitary melanotroph tumor incidence |
J:77982
|
|
normal
vision/eye phenotype |
J:77982
|
Rb1tm2Mlh/Rb1+
either: 129P2/OlaHsd-Rb1tm2Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N)
|
abnormal dorsal root ganglion morphology |
J:2498
|
|
increased pituitary melanotroph tumor incidence |
J:20542
|
|
normal
neoplasm |
J:2498,
J:20542
|
Rb1tm2Mlh/Rb1tm2Mlh
either: 129P2/OlaHsd-Rb1tm2Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N)
|
abnormal definitive hematopoiesis |
J:2498
|
|
abnormal dorsal root ganglion morphology |
J:2498
|
|
abnormal erythrocyte morphology |
J:2498
|
|
abnormal erythropoiesis |
J:2498,
J:20542
|
|
abnormal frontal lobe morphology |
J:2498
|
|
abnormal lens fiber morphology |
J:20542
|
|
abnormal myelopoiesis |
J:2498
|
|
decreased erythrocyte cell number |
J:2498
|
|
decreased hepatocyte number |
J:20542
|
|
dilated fourth ventricle |
J:2498
|
|
dilated liver sinusoidal space |
J:2498
|
|
embryonic growth retardation |
J:2498
|
|
embryonic lethality, complete penetrance |
J:2498
|
|
flat forehead |
J:2498
|
|
increased apoptosis |
J:2498
|
|
increased megakaryocyte cell number |
J:2498
|
|
neurodegeneration |
J:2498,
J:20542
|
|
pale yolk sac |
J:2498
|
|
normal
vision/eye phenotype |
J:20542
|
Rb1tm3Fad/Rb1tm3Fad
involves: 129S1/Sv * 129X1/SvJ
|
decreased tumor-free survival time |
J:249124
|
|
increased lymphoma incidence |
J:249124
|
Rb1tm3Tyj/Rb1tm3.1Tyj
Tg(Nes-cre)1Atp/0
involves: 129S4/SvJae * FVB/N
|
abnormal lens development |
J:81643
|
|
abnormal myogenesis |
J:81643
|
|
abnormal neuron differentiation |
J:81643
|
|
normal
hematopoietic system phenotype |
J:81643
|
|
hunched posture |
J:81643
|
|
increased brain size |
J:81643
|
|
increased brain weight |
J:81643
|
|
increased neuron apoptosis |
J:81643
|
|
normal
liver/biliary system phenotype |
J:81643
|
|
neonatal lethality, complete penetrance |
J:81643
|
Rb1tm3Tyj/Rb1tm3Tyj
involves: 129S4/SvJae
|
normal
neoplasm |
J:172430
|
|
polyploidy |
J:172430
|
Rb1tm3Tyj/Rb1tm3Tyj
Tg(KRT14-cre)8Brn/0
involves: 129S4/SvJae * C57BL/6 * FVB
|
abnormal epidermis stratum granulosum morphology |
J:101623
|
|
abnormal epidermis suprabasal layer morphology |
J:101623
|
|
epidermal hyperplasia |
J:101623
|
Rb1tm3Tyj/Rb1tm3Tyj
Tg(Nes-cre)1Atp/0
involves: 129S4/SvJae * FVB/N
|
abnormal retina ganglion layer morphology |
J:91406
|
|
abnormal retina inner nuclear layer morphology |
J:91406
|
|
decreased retina photoreceptor cell number |
J:91406
|
|
decreased tumor-free survival time |
J:91406
|
|
disorganized retina inner nuclear layer |
J:91406
|
|
increased pituitary gland tumor incidence |
J:91406
|
|
increased retina apoptosis |
J:91406
|
|
thin retina outer nuclear layer |
J:91406
|
|
transmission ratio distortion |
J:91406
|
Rb1tm3Tyj/Rb1tm3Tyj
Tg(Pax6-cre,GFP)2Pgr/0
involves: 129S4/SvJae
|
abnormal retina inner nuclear layer morphology |
J:91406
|
|
abnormal retina inner plexiform layer morphology |
J:91406
|
|
abnormal retina morphology |
J:91406
|
|
absent retina bipolar cells |
J:91406
|
|
decreased retina ganglion cell number |
J:91406
|
|
gliosis |
J:91406
|
|
increased retina apoptosis |
J:91406
|
|
thin retina inner nuclear layer |
J:91406
|
|
thin retina inner plexiform layer |
J:91406
|
|
thin retina outer nuclear layer |
J:91406
|
Rb1tm3Tyj/Rb1tm3Tyj
Tg(Pax6-cre,GFP)2Pgr/0
involves: 129S4/SvJae * 129X1/SvJ * C57BL/6 * FVB/N
|
abnormal retina morphology |
J:119919
|
|
increased retina apoptosis |
J:119919
|
Rb1tm3Tyj/Rb1tm3Tyj
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
involves: 129S4/SvJae * C57BL/6J * CD-1
|
normal
neoplasm |
J:136693
|
Excel File
Analysis Tools